To hear about similar clinical trials, please enter your email below
Trial Title:
Investigation of the Effect of Training on the Side Effects of Chemotherapy Given Via the Mobile Health Application on the Quality of Life in Colorectal Cancer Patients
NCT ID:
NCT05940740
Condition:
Colorectal Cancer
Mobile Phone Use
Nurse's Role
Conditions: Official terms:
Colorectal Neoplasms
Conditions: Keywords:
Colorectal Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Colorectal-Mobile application
Description:
The use of Colorectal-Mobile application by the patients on a daily basis by the
researcher will be monitored remotely via the management platform of the usage status of
the mobile health application.
Arm group label:
INTERFERENCE (EXPERIMENT)
Summary:
The incidence of colorectal cancer ranks fourth worldwide after lung, prostate and breast
cancers. Although chemotherapy has an important place in the treatment of colorectal
cancers, it can cause side effects such as diarrhea and fatigue in patients. Cancer
patients' ability to cope with treatment side effects can be benefited from technological
developments. Studies have shown that mobile health applications reduce symptom
experience and increase quality of life in patients with breast cancer and leukemia.
Detailed description:
The incidence of colorectal cancer ranks fourth worldwide after lung, prostate and breast
cancers. Although chemotherapy has an important place in the treatment of colorectal
cancers, it can cause side effects such as diarrhea and fatigue in patients. Cancer
patients' ability to cope with treatment side effects can be benefited from technological
developments. Studies have shown that mobile health applications reduce symptom
experience and increase quality of life in patients with breast cancer and leukemia. This
research was planned as a quasi-experimental study with a pre-test-post-test control
group in order to examine the effects of the mobile health application developed
according to the Self-Care Disability Theory and the training given for chemotherapy side
effects on the quality of life of colorectal cancer patients. The sample of the study
will consist of patients who underwent chemotherapy outpatient (23 intervention group and
23 control group) with the diagnosis of colorectal cancer in the Internal Medicine
Medical Oncology outpatient clinic of Istanbul University-Cerrahpasa Cerrahpasa Medical
Faculty. Simple random sampling method, which is one of the probabilistic sampling
methods, will be used to determine the intervention and control groups. Data will be
obtained (pre-test) with the Patient Information Form, the Self-Care Needs Assessment
Form, the Nightingale Symptom Assessment Scale (N-SDS), and the Cancer Treatment
Functional Assessment-Colorectal Scale (FACT-C). Training will be provided to the
initiative group through the mobile health application. Symptom management and quality of
life will be evaluated by using data collection tools after the 1st and 2nd cycles of
chemotherapy in intervention group patients. A face-to-face meeting with the initiative
group is planned every two weeks. Once a week, an message will be sent to the
intervention group patients reminding them to use the mobile health application. Control
group patients will continue to receive routine treatment and follow-up. A post-test will
be applied to the intervention and control groups in the third month (12 weeks after the
first interview). In this study, it is aimed to compare the effectiveness of routine
treatment and care with the use of a mobile health application developed according to the
Self-Care Insufficiency Theory, considering the developments in today's technology, and
to evaluate the effects of the two methods on the control of symptoms that may occur due
to chemotherapy side effects in colorectal cancer patients and their care needs.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Chemotherapy was started with the diagnosis of colorectal cancer,
- Receiving adjuvant chemotherapy,
- His psychological and general condition is suitable for the interview and
- Identified as colorectal cancer patients who volunteered to participate in the study
Exclusion Criteria:
- Not diagnosed with colorectal cancer
- Not diagnosed adjuvant chemotherapy
Gender:
All
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Beykent University
Address:
City:
Istanbul
Zip:
34528
Country:
Turkey
Status:
Recruiting
Contact:
Last name:
Neslisah Yasar Kartal, phd candidate
Phone:
5386453541
Phone ext:
+90
Email:
neslisahysr@gmail.com
Start date:
March 1, 2023
Completion date:
October 31, 2023
Lead sponsor:
Agency:
NESLISAH YASAR KARTAL
Agency class:
Other
Collaborator:
Agency:
Saglik Bilimleri Universitesi
Agency class:
Other
Source:
University of Beykent
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05940740